Allan D. Kirk MD PhD
Hepatobiliary Surgery, Pancreas, Transplantation
David C. Sabiston, Jr. Professor and Chairman of Surgery, Duke University School of Medicine; Surgeon-in-Chief, Duke University Health System
Join to View Full Profile
2301 Duke Medical Ctr7th Floor, Room 7690 HAFS BuildingDurham, NC 27710
Phone+1 919-681-3445
Dr. Kirk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Allan Kirk is Chair of the Department of Surgery at Duke University and Surgeon-in-Chief for the Duke Health System. He received his medical degree and PhD from Duke University School of Medicine and has been in practice 30 years. He specializes in transplantation and is experienced in kidney and pancreas transplantation, transplant surgery, hepatopancreatobiliary surgery, pediatric transplant surgery, and immune tolerance.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Abdominal Transplant Surgery, 1995 - 1997
Duke University HospitalResidency, Surgery, 1987 - 1995
Duke UniversityPhD, 1989 - 1992
Duke University School of MedicineClass of 1987
Certifications & Licensure
GA State Medical License 2007 - 2026
NC State Medical License 1990 - 2026
VA State Medical License 1998 - 2022
WI State Medical License 1995 - 2007
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Elected Member National Academy of Medicine
- Elected member American Surgical Association
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Clinical Trials
- Belatacept Post Depletional Repopulation to Facilitate Tolerance Start of enrollment: 2007 Dec 01
- Immune Development in Pediatric Transplantation (IMPACT) Start of enrollment: 2009 Jul 01
- Immune Monitoring and Assay Development in Organ Transplant Recipients Start of enrollment: 2007 Nov 01
Publications & Presentations
PubMed
- Corrigendum to "Antibodies to angiotensin II type 1 receptor and endothelin type A receptor are associated with cytokine production enriched for type 2 immune response...Meghan H Pearl, Lucia Chen, Tristan Grogan, Niloufar Nikfarjam, Paul C Grimm
American Journal of Transplantation. 2026-03-01 - 1 citationsDual costimulation blockade with the CD154-specific fusion protein dazodalibep and belatacept for prophylaxis of kidney allograft rejection.Flavio Vincenti, Jun Shoji, David Wojciechowski, Jim Kim, Wenjing Xu
American Journal of Transplantation. 2026-02-03 - A Report of Four Depletional Induction Strategies in Non-Human Primate Islet Xenotransplantation.Meghan Hu, Qimeng Gao, Joseph Ladowski, Imran Anwar, Isabel DeLaura
Xenotransplantation. 2026-01-16
Press Mentions
Duke Heart Pulse — February 23, 2025February 23rd, 2025- ‘It’s Spare Parts for People’: Blood Vessels Grown in a LabOctober 21st, 2024
- Clinetic Establishes Partnership with 10th Leading Academic Health SystemFebruary 15th, 2023
Grant Support
- Advanced Immunobiology Traning Program for SurgeonsDUKE UNIVERSITY2019–2029
- Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectorsDUKE UNIVERSITY2022–2027
- The impact of targeting CD40-CD154 pathway in nonhuman primate vascularized composite allograft modelDUKE UNIVERSITY2024–2025
- Neonatal porcine islet xenografts for the treatment of type 1 diabetesDUKE UNIVERSITY2010–2025
- Adjuvant Therapies Improving The Anti-Rejection Effects Of Costimulation BlockadeNational Institute Of Allergy And Infectious Diseases2009–2012
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
